Nexplanon (etonogestrel) is a prescription birth control device that’s used to prevent pregnancy. Nexplanon’s cost may depend on factors such as whether you have health insurance. Nexplanon is a form ...

Nexplanon is a birth control device. It’s approved to help prevent pregnancy, so you should not use it during pregnancy. It’s important to note that no birth control is 100% effective at preventing ...

Nexplanon is a prescription drug used to help prevent pregnancy. Nexplanon can cause mild to severe side effects, such as weight gain, nausea, and changes in period bleeding. Nexplanon is used to help ...

Nexplanon is a brand-name birth control implant that a healthcare professional inserts under the skin of your upper arm. It is very effective at preventing pregnancy for up to 3 years. Nexplanon ...

If, like me, you keep seeing those "I armor up" commercials while binge-watching Broad City on Hulu, you might be curious about how Nexplanon works. Just how effective is Nexplanon, the birth control ...

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...

Clinical data support a 5-year duration for the Nexplanon implant, with no reported pregnancies during the extended 2-year study period. The Food and Drug Administration (FDA) has extended the ...

When it comes to choosing a contraceptive method, there are a number of options for women. You're probably aware of the Pill and getting an IUD, and you may also have heard of the Depo-Provera shot ...

(RTTNews) - Organon (OGN) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON (etonogestrel implant). NEXPLANON is ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Organon (NYSE:OGN) received ...

CEO Kevin Ali stated that Q1 2025 results met expectations, with Nexplanon achieving double-digit growth and projected to exceed $1 billion in revenue for the year. He highlighted the success of the ...